6 billion over the last year.    Accusations of fraud and drug price gouging have sent investors   fleeing from the company, and it’s holding over $30 billion in   debt. The company’s annual report cites that debt (and any   reduction in cash flow hampering its ability to pay it) as a   risk.  " ’    From the report: ’ ’   Valeant is not the only company that could get hit if the   interest deduction is eliminated. 